您当前的位置:
首页 >
文章列表页 >
PI3K/AKT regulates the expression of PD-L1 via Nrf2 pathway in non-small cell lung cancer
更新时间:2026-01-27
    • PI3K/AKT regulates the expression of PD-L1 via Nrf2 pathway in non-small cell lung cancer

    • China Oncology   Vol. 30, Issue 6, Pages: 419-427(2020)
    • DOI:10.19401/j.cnki.1007-3639.2020.06.003    

      CLC: R734.2
    • Published Online:15 July 2020

      Published:15 July 2020

    移动端阅览

  • 王 静, 陈 洁, 胡 春, et al. PI3K/AKT regulates the expression of PD-L1 via Nrf2 pathway in non-small cell lung cancer[J]. China Oncology, 2020, 30(6): 419-427. DOI: 10.19401/j.cnki.1007-3639.2020.06.003.

  •  
  •  
icon
试读结束,您可以激活您的VIP账号继续阅读。
去激活 >
icon
试读结束,您可以通过登录账户,到个人中心,购买VIP会员阅读全文。
已是VIP会员?
去登录 >

0

Views

3906

下载量

0

CSCD

Alert me when the article has been cited
提交
Tools
Download
Export Citation
Share
Add to favorites
Add to my album

Related Articles

Advances in immune checkpoint inhibitor therapy for breast cancer: research progress and future directions
Effect of PD-L1 expression on the efficacy of pemetrexed-based chemotherapy in patients with advanced lung adenocarcinoma and its mechanism
Advances and future prospects of immunotherapy in bladder cancer

Related Author

Cheng ZENG
Yuanyi WANG
Jiani WANG
Fei MA
施茂林
柏玉娣
王 超
李思琪

Related Institution

Department of Medical Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College
西南医科大学临床医学院
中国人民解放军西部战区总医院肿瘤诊治中心
西南交通大学医学院
中国人民解放军西部战区总医院病理科
0